Allurion Technologies (ALURD) Return on Invested Capital (2023 - 2024)
Allurion Technologies' (ALURD) quarterly Return on Invested Capital came in at 0.01% in Q4 2024, little changed YoY from 0.01% in Q1 2024, and down 75.54% on a QoQ basis from 0.01% in Q3 2024.
Allurion Technologies (ALURD) Return on Invested Capital (2023 - 2024) Analysis & Trends
Allurion Technologies (ALURD) has 2 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2024.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.01% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.01% (changed 0.0% YoY) and the FY2023 annual result came in at 0.02%, changed N/A from the prior year.
- Return on Invested Capital retreated to 0.01% in Q4 2024, from 0.01% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2024 to a low of 0.01% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 0.01% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 0.01% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 0.01% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.04% |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.01% |